Jill Roberts Center for Inflammatory Bowel Disease

Baseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients With Inflammatory Bowel Disease.

TitleBaseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients With Inflammatory Bowel Disease.
Publication TypeJournal Article
Year of Publication2020
AuthorsLukin DJ, Kumar A, Hajifathalian K, Sharaiha RZ, Scherl EJ, Longman RS
Corporate AuthorsJill Roberts Center Study Group Study Group, Weill Cornell Medicine-Gastrointestinal Study Group
JournalGastroenterology
Volume159
Issue4
Pagination1541-1544.e2
Date Published2020 Oct
ISSN1528-0012
KeywordsAbdominal Pain, Adult, Aged, Antibodies, Monoclonal, Humanized, Biological Factors, Case-Control Studies, Colitis, Ulcerative, Comorbidity, Coronavirus Infections, COVID-19, Critical Care, Crohn Disease, Diarrhea, Female, Gastrointestinal Agents, Humans, Intubation, Intratracheal, Longitudinal Studies, Male, Middle Aged, New York, Pandemics, Pneumonia, Viral, Prevalence, Risk Factors, Severity of Illness Index, Steroids, Ustekinumab
DOI10.1053/j.gastro.2020.05.066
Alternate JournalGastroenterology
PubMed ID32479824
PubMed Central IDPMC7256492
Grant ListR01 DK114252 / DK / NIDDK NIH HHS / United States
R01 DK120985 / DK / NIDDK NIH HHS / United States